Launch offer: 7 days freeLaunch offer: 7-day free trial for investors and Research Analysts.

Start free trial
Close
NIFTY 50

Acutaas Chemicals share price

Acutaas Chemicals Ltd. · NSE: ACUTAAS · Healthcare

₹3,137.70 −77.60 −2.41%
Last session · 23 Oct 2026, 16:08 IST

Price, one year

1 year agoLow 1,401.50 · High 3,694.80Latest close
1W+0.17%
1M−2.36%
3M−9.29%
6M+29.49%
1Y+109.61%

Price range

Open
₹3,219.40
High
₹3,236.70
Low
₹3,085.00
Previous close
₹3,215.30
Volume
3.5 L
Market cap
₹25,689 Cr
Day range
52-week range

Key statistics

Results to 30 Jun 2026 · Consolidated
P/E (TTM)
66.5
Price to book
15.5
Return on equity
23.4%
EPS (TTM)
₹47.17
Book value / share
₹201.97
Debt to equity
0.02
Revenue (TTM)
₹1,462 Cr
Net profit (TTM)
₹386 Cr
Sales growth, YoY
+59.1%
Profit growth, YoY
+67.7%
Operating margin
37.1%
Net margin
26.4%
Sales CAGR, 3 years
+29.5%
Profit CAGR, 3 years
+62.3%
Promoter holding
32.66%
Promoter shares pledged
0.00%
From the company's results filed with NSE; TTM is the last four quarters. Ratios use the latest price.

Shareholding pattern

% of shares
HolderSep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters32.6632.6632.6632.6632.66
Foreign institutions16.8516.6719.4821.6122.62
Domestic institutions22.5921.7019.6019.5619.40
Mutual funds15.8115.1113.8614.1714.44
Retail and others22.7923.5323.2121.7221.15

Results and announcements

Latest results (quarter to 30 Jun 2026) filed 24 Jul 2026. results: 27 Oct 2026.

  • 17 Oct 2026 · Deal
    Acquisition
    Acutaas Chemicals Limited has informed the Exchange about Acquisition
Exchange filings as published on NSE; routine filings are left out.

Peers in Healthcare

All Healthcare stocks
CompanyPriceChangeMarket capP/E
Sun Pharmaceutical IndustriesSUNPHARMA ₹1,748.00 −0.57% ₹4,19,404 Cr 34.7
Divi's LaboratoriesDIVISLAB ₹8,950.00 −2.31% ₹2,37,594 Cr 81.2
Torrent PharmaceuticalsTORNTPHARM ₹4,524.40 −1.97% ₹1,72,094 Cr 76.4
Zydus LifesciencesZYDUSLIFE ₹1,129.40 −0.49% ₹1,12,658 Cr 25.2
Apollo Hospitals EnterpriseAPOLLOHOSP ₹7,730.00 +1.65% ₹1,11,146 Cr 53.2
CiplaCIPLA ₹1,338.00 +0.53% ₹1,08,093 Cr 32.1
Laurus LabsLAURUSLABS ₹1,970.00 −1.62% ₹1,06,442 Cr 97.2
Dr. Reddy's LaboratoriesDRREDDY ₹1,229.50 −0.77% ₹1,02,624 Cr 36.6
Mankind PharmaMANKIND ₹2,212.60 −2.77% ₹91,390 Cr 44.7
Aurobindo PharmaAUROPHARMA ₹1,571.70 −2.43% ₹90,432 Cr 24.6

Frequently asked questions

What is the share price of Acutaas Chemicals today?

Acutaas Chemicals (NSE: ACUTAAS) was at ₹3,137.70 on 23 Oct 2026, a change of −2.41% from the previous close.

What are the 52-week high and low of Acutaas Chemicals?

Over the last 52 weeks Acutaas Chemicals traded between ₹1,470.00 and ₹3,740.00 (daily highs and lows on NSE on 23 Oct 2026).

What is the market capitalisation of Acutaas Chemicals?

About ₹25,689 Cr at the latest price, with a P/E of 66.5, a price-to-book of 15.5, a return on equity of 23.4%. Ratios use the company's latest reported results.

Who owns Acutaas Chemicals shares?

According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 32.66%, foreign institutions 22.62%, domestic institutions 19.40%.

Which sector and indices does Acutaas Chemicals belong to?

NSE classifies Acutaas Chemicals under Healthcare; it is a member of Nifty 500.

Follow Acutaas Chemicals with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.

Start free trial